Melanin affinity and its possible role in neurodegeneration (Q38118939)

29 August 2017

title

Melanin affinity and its possible role in neurodegeneration (English)

1 reference

29 August 2017

1 reference

Oskar Karlsson

1

1 reference

29 August 2017

Nils Gunnar Lindquist

series ordinal

2

1 reference

29 August 2017

publication date

3 July 2013

1 reference

Journal of Neural Transmission

29 August 2017

published in

1 reference

29 August 2017

volume

120

1 reference

29 August 2017

issue

12

1 reference

29 August 2017

page(s)

1623-1630

1 reference

Applications of affinity chromatography to the study of drug-melanin binding interactions

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

Biomagnification of cycad neurotoxins in flying foxes: implications for ALS-PDC in Guam

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

Histochemical observations on rodent brain melanin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

Pathologic findings in the retinal pigment epitheliopathy associated with the amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

Amphetamine adducts of melanin intermediates demonstrated by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

Genes and the environment in neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

A retinopathy on Guam with high prevalence in Lytico-Bodig

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

Selectivity of the parkinsonian neurotoxin MPTP: toxic metabolite MPP+ binds to neuromelanin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

Evidence for neuromelanin involvement in MPTP-induced neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

Retinal pigment epithelium melanin and ocular toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

Epidemiology of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

Distribution of an 125I-labelled chloroquine analogue in a pregnant macaca monkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

Iron-binding characteristics of neuromelanin of the human substantia nigra.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

Anti-melanin antibodies are increased in sera in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

Studies on neuromelanin: II. Melanin in the brainstems of infants and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

Family history of melanoma and Parkinson disease risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

Tyrosinase exacerbates dopamine toxicity but is not genetically associated with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

Evidence for specific phases in the development of human neuromelanin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

Pigmentation genes link Parkinson's disease to melanoma, opening a window on both etiologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

Nicotine is neuroprotective when administered before but not after nigrostriatal damage in rats and monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

The IFPCS presidential lecture: a chemist's view of melanogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

Chemistry of mixed melanogenesis--pivotal roles of dopaquinone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

Retention of the cyanobacterial neurotoxin beta-N-methylamino-l-alanine in melanin and neuromelanin-containing cells--a possible link between Parkinson-dementia complex and pigmentary retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

Chloroquine retinopathy: lipofuscin- and melanin-related fundus autofluorescence, optical coherence tomography and multifocal electroretinography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

The parkinsonian models: invertebrates to mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

MPTP toxicity: implications for research in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

Autoimmunity, dendritic cells and relevance for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

Interaction between chemicals and melanin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

Studies on the mechanism of drug-binding to melanin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

Neuromelanin enhances the toxicity of α-synuclein in SK-N-SH cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

Neuromelanin and its possible protective and destructive properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

Meta-analysis of the relationship between Parkinson disease and melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

Pheomelanin as a binding site for drugs and chemicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

Aging of the nigrostriatal system in the squirrel monkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

Neuromelanin is an immune stimulator for dendritic cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

Long-term retention of neurotoxic beta-carbolines in brain neuromelanin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

The role of alpha-synuclein in melanin synthesis in melanoma and dopaminergic neuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

ALS and PDC of Guam: forty-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

Amyotrophic lateral sclerosis and parkinsonism-dementia complex of Guam: changing incidence rates during the past 60 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

Melanin-targeted preclinical PET imaging of melanoma metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

Properties and function of the ocular melanin--a photobiophysical view

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

Neurochemical findings in the MPTP model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

Neuromelanin inhibits enzymatic activity of 26S proteasome in human dopaminergic SH-SY5Y cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

Current challenges in understanding melanogenesis: bridging chemistry, biological control, morphology, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

The ALS/PDC syndrome of Guam and the cycad hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

Parkinson disease in twins: an etiologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

Occupation and risk of parkinsonism: a multicenter case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

Ocular toxicity due to chloroquine and hydroxychloroquine: electrophysiological and visual function correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

Accumulation of chorio-retinotoxic drugs in the foetal eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

The structure of neuromelanin as studied by chemical degradative methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

Characterization of melanin in human iridal and choroidal melanocytes from eyes with various colored irides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

Complete ascertainment of Parkinson disease in the Swedish Twin Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

Neuromelanin of the substantia nigra: a neuronal black hole with protective and toxic characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

Neuromelanin activates microglia and induces degeneration of dopaminergic neurons: implications for progression of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

Human neuromelanin: an endogenous microglial activator for dopaminergic neuron death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

Overexpression of human alpha-synuclein causes dopamine neuron death in primary human mesencephalic culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1062-5

Current update and trends in melanin pigmentation and melanin biology.

21 January 2018

1 reference

12 December 2020

The ALS/PDC syndrome of Guam and the cycad hypothesis

1 reference

12 December 2020

The Melanin Affinity of Chloroquine and Chlorpromazine Studied by Whole Body Autoradiography

1 reference

12 December 2020

Activation of microglia by human neuromelanin is NF-kappaB dependent and involves p38 mitogen-activated protein kinase: implications for Parkinson's disease

1 reference

12 December 2020

Magnetic beads method for determination of binding of drugs to melanin

1 reference

12 December 2020

α-Synuclein aggregation and neurodegenerative diseases

1 reference

12 December 2020

Clinical and neuropathological aspects of autosomal recessive juvenile parkinsonism

1 reference

12 December 2020

Anatomical localisation of neuromelanin in the brains of the frog and tadpole. Ultrastructural comparison of neuromelanin with other melanins.

1 reference

12 December 2020

Tyrosinase is not detected in human catecholaminergic neurons by immunohistochemistry and Western blot analysis

1 reference

12 December 2020

Accumulation in vitro of 35 S-chlorpromazine in the neuromelanin of human substantia nigra and locus coeruleus

1 reference

12 December 2020

Incorporation of D-amphetamine into pigmented guinea-pig hair

1 reference

12 December 2020

The concentration of phenothiazines in the eye of experimental animals

1 reference

12 December 2020

Selective incorporation of the prototype melanoma seeker thiourea into nascent melanin: a chemical insight

1 reference

12 December 2020

A cohort study of amyotrophic lateral sclerosis and parkinsonism-dementia on Guam and Rota

1 reference

12 December 2020

The absolute concentration of nigral neuromelanin, assayed by a new sensitive method, increases throughout the life and is dramatically decreased in Parkinson's disease

1 reference

12 December 2020

1 reference

12 December 2020

Tyrosine hydroxylase and methionine-enkephalin in the human mesencephalon

1 reference

12 December 2020

1 reference

12 December 2020

THE REACTION OF UVEAL PIGMENT IN VITRO WITH POLYCYCLIC COMPOUNDS

1 reference

12 December 2020

FURTHER STUDIES CONCERNING THE ACCUMULATION OF POLYCYCLIC COMPOUNDS ON UVEAL MELANIN

1 reference

12 December 2020

Pigmentation in the nucleus substantiae nigrae of mammals.

1 reference

12 December 2020

Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP?

1 reference

12 December 2020

Autoradiography of [14C]paraquat or [14C]diquat in frogs and mice: accumulation in neuromelanin

1 reference

12 December 2020

Accumulation of a parkinsonism-inducing neurotoxin in melanin-bearing neurons: autoradiographic studies on 3H-MPTP

1 reference

12 December 2020

Neuromelanin associated redox-active iron is increased in the substantia nigra of patients with Parkinson's disease.

1 reference

12 December 2020

Accumulation of drugs on melanin.

1 reference

12 December 2020

Iron and ferritin in substantia nigra in Parkinson's disease

1 reference

12 December 2020

Increased melanoma risk in Parkinson disease: a prospective clinicopathological study

1 reference

12 December 2020

Studies on the melanin affinity of haloperidol.

1 reference

12 December 2020

The ALS/PDC syndrome of Guam and the cycad hypothesis

1 reference

12 December 2020

The ALS/PDC syndrome of Guam and the cycad hypothesis

1 reference

12 December 2020

Distribution of Labeled Chloroquine in the Inner Ear

1 reference

12 December 2020

Uveal pigment and phenothiazine compounds

1 reference

12 December 2020

Evidence for specific phases in the development of human neuromelanin

1 reference

12 December 2020

Amyotrophic lateral sclerosis and parkinsonism-dementia on Guam, 1945-1972. II. Familial and genetic studies

1 reference

12 December 2020

Increased expression of α-synuclein in aged human brain associated with neuromelanin accumulation

1 reference

12 December 2020

10.1007/S00702-013-1062-5

Identifiers

DOI

1 reference

29 August 2017

1 reference